As we try to keep up with a world being transformed by data driven decision making, the potential value of a tool that simulates the future of public health is profound. On this episode of the AWS Health Innovation Podcast, Yin He from AWS Startups speaks with John Cordier, the CEO & Co-Founder of Epistemix, who built a platform for running realistic simulations of human populations, simulations that reveal crucial points of leverage where a single decision can have extraordinary impact, providing game-changing capabilities to health plans and systems. Population Health Simulation [02:05]: Discover Epistemix's synthetic population health engine and learn about John's career, dedicated to advancing public health. COVID-19 & Behavioral Shifts [06:28]: Learn about the pivotal role of information and behavior changes in public health, using COVID-19 as a case study. Strategic Health Planning [13:29]: Deep dive into Epistemix's role in helping health plans and systems develop strategies to improve outcomes, access, and equity. Technology [17:02]: Explore the innovative technology behind Epistemix's simulations, offering highly granular data across the US and beyond. Improving Health Equity [19:52]: John shares insights on addressing social determinants in health through Epistemix's simulations. The Power of Simulation [26:48]: Understand the dynamic nature of Epistemix's approach to simulation versus prediction in public health. "Simulation, Not Prediction", read the blog mentioned in this episode: Get in touch with AWS here to learn how we can help your organization accelerate healthcare innovation. Please take a moment and let us know what you think of the podcast, access our feedback survey here.

Imagine the convenience of getting a full suite of blood tests, completed in just 30 minutes, during a routine visit to your GP. That's the reality Truvian Health is making possible. On this episode of the AWS Health Innovation Podcast, host Alex Merwin and Truvian CEO Jay Srinivasan discuss how Truvian is transforming blood diagnostics, offering rapid, lab-accurate health tests, and setting a new precedent in a field once marred by controversy. Truvian's Mission [02:03]: Truvian is on a mission to bring central lab quality testing closer to patients, providing results from only 300 microliters of blood within half an hour. A New Diagnostic Era [07:04]: Jay shares his vision for democratizing healthcare through accessible, high-quality diagnostics, building on past industry challenges. Evidence-Based Innovation [11:07]: An inside look at Truvian's clinical trials and proactive FDA engagement to deliver reliable healthcare solutions. Go to Market Strategy [16:45]: How Truvian plans to penetrate high-need markets and enable point-of-care diagnostics to streamline healthcare and reduce costs. Zero to One [20:40]: The origin story of Truvian, the scientific and technological innovation driving its development, and the challenges they overcame during the pandemic. Cultivating Diverse Talent [26:00]: The company culture that fosters leadership and innovation across a varied team of experts. Truvian's Ambition [31:10]: The roadmap to introducing seamless diagnostic data flow and integration within healthcare systems. Digital Twins [36:58]: Exploring the future of personalized care through the lens of digital health twins and the potential for Truvian to play a key role role. Discover Truvian's work in revolutionizing blood testing and how their groundbreaking diagnostic device could redefine patient experiences and clinical outcomes. Visit Truvian's website to learn more about their cutting-edge technology. Get in touch with AWS here to learn how we can help your organization accelerate healthcare innovation. Please take a moment and let us know what you think of the podcast, access our feedback survey here.

Imagine a world where clinical teams can predict life-threatening events hours before they happen. In this episode, we welcome Paul Roscoe, CEO of CLEW, who introduces us to their clinical command center which harnesses AI to enable earlier interventions, thus improving patient & business outcomes for hospitals. Our host, Alex Merwin, Head of Growth, Healthcare & Life Sciences Startups, asks Paul to share details about CLEW's regulatory strategy, their seamless integration into clinician workflows, and the art of attracting and developing exceptional talent. CLEW extends ICU capacity by enabling proactive care. With their innovative approach, they are redefining how critical care is delivered, offering full situational awareness of patient conditions to improve clinical outcomes. Identifying Critical Risks [01:41]: CLEW's AI platform revolutionizes ICU patient care by predicting critical health events, enabling timely interventions that save lives and reduce healthcare costs. Paul's Healthcare Journey [04:52]: Paul's career, rooted in healthcare from accounting to impact-driven work, led him to Clew, where technology enhances patient care without replacing the human touch. Regulatory Pathways [07:12]: CLEW's strategic approach to FDA clearance underscores their commitment to credibility and the importance of robust, transferable predictive models in clinical settings. Expanding Care Horizons [10:49]: CLEW's technology transcends the ICU, offering system-wide healthcare optimization and revealing the potential for remote patient monitoring and comprehensive hospital care. Value-Driven AI [19:25]: CLEW's AI isn't just innovative; it's a critical tool for clinicians, driving efficiency and efficacy in patient care while addressing the financial pressures of healthcare systems. Integrating Clinical Workflows [24:06]: CLEW's platform seamlessly integrates with existing EMR systems, enhancing clinical workflows and ensuring that predictions translate into effective, immediate actions. Building a Talented Team [28:17]: Paul emphasizes the importance of assembling a world-class team, fostering a culture of transparency, and maintaining agility to advance CLEW's global mission in patient care. Get in touch with AWS here to learn how we can help your organization accelerate healthcare innovation. Please take a moment and let us know what you think of the podcast, access our feedback survey here.

Robin Shah, Co-Founder of Thyme Care, shares his journey in oncology and how the pandemic shaped their approach. Thyme Care's patient-centric model streamlines cancer care, focusing on outcomes and economics. The podcast also delves into their hybrid working model and talent acquisition post-Series B funding.

How is AI transforming the way hopsitals operate? Guy Spigelman, the EMEA lead for Healthcare and Life Sciences Startups at AWS, welcomes Elad Walach, the Founder and CEO of Aidoc to the show for a candid and lighthearted conversation. Aidoc offers a leading healthcare AI platform used in over 1,000 medical centers globally, analyzing more than a million patients a month. In this episode, we discuss Aidoc's evolution, Elad's journey as a first-time founder, and how to scale a healthcare startup to over 400 employees while attracting more than $250M in financing from leading investors. Here's what you'll learn: Beyond Digital Health [01:25] - Elad and Guy discuss why the term "Digital Health" is limiting and how Aidoc focuses on clinical outcomes, not just technology. They also cover the challenges of FDA clearances and the unique path Aidoc has taken. Who is the Customer? [05:27] - We explore the evolution of Aidoc's customer focus, from radiologists to enterprise-level deals with hospital systems, and how their priorities have changed over the past two years. Scaling Challenges [09:18] - Elad shares Aidoc's journey from a radiology-focused startup to an enterprise-level Clinical AI provider. We hear about the challenges of scaling and competing against larger incumbents in the healthcare industry, while also learning about Elad's evolution as a founder and leader. It's All About the People [15:00] - Aidoc's internal culture is fuelled by patient and physician stories. We discuss the importance of culture in scaling a startup and how Aidoc ensures they are hiring and developing great talent. AI Hype vs. Reality [21:39] - Thanks to the proliferation of chatbots, AI is on everyone's mind. Elad talks about the responsibility entrepreneurs deploying AI in healthcare have, emphasizing the need for education and better planning, to avoid an "AI winter" where we burn early adopters and lose a golden opportunity to accelerate innovation in healthcare. Future Ambitions [29:09] - Elad shares Aidoc's future ambitions, from an IPO to expanding AI's impact in healthcare. We also end with some sage advice for healthcare founders. Get in touch with AWS here to learn how we can help your organization accelerate healthcare innovation. Please take a moment and let us know what you think of the podcast, access our feedback survey here.

Ever notice how some people seem to be naturally resistant to certain diseases? Today, we're diving into the world of natural protective antibodies with Alchemab Therapeutics. Alchemab is developing a pipeline of antibody therapeutics for hard-to-treat cancers, neurodegenerative conditions, and infectious diseases. Amrita Sarkar, Principal Healthcare and Life Sciences Startups Business Development Manager at AWS, speaks with Young Kwon, the CEO of Alchemab, about his journey, the company's unique approach to drug discovery, and how technology is accelerating their progress. Therapeutic Insights from the Immune System [01:00] - Discover how Alchemab identifies resilient individuals to chronic diseases and leverages insights about their immune systems for drug development. Learn how their approach is revolutionizing how we think about treating hard-to-treat conditions like cancer and neurodegenerative disorders. From Benchside to Industry [02:53] - Learn about Young Kwon's unique career trajectory, from academia to venture capital to TechBio CEO, and how his diverse experiences have shaped his leadership at Alchemab. Placing Bets [07:39] - Why is Alchemab focusing on cancer and neurodegenerative disorders? Understand their unique approach to identifying resilient individuals and why they've selected their disease areas of focus. Bio <> Tech Convergence [14:52] - Explore how advancements in cloud computing and machine learning are enabling Alchemab to accelerate drug discovery. This is particularly relevant as the biotech industry grapples with the challenges of ever growing datasets both in terms of size and complexity. Pipeline & Partnerships [19:30] - A guided tour of Alchemab's preclinical programs and why pharma partnerships are crucial for their growth. Scaling Challenges [23:35] - Alchemab faces unique technical & business challenges as they scale. Learn how they navigate these hurdles in an environment where competition for compute resources is hotter than ever as the world flocks to deploy AI in every industry. Advice to Founders - Culture First [25:39] - Young Kwon shares his perspective on how to be an effective steward of strong team culture and how he approaches his role as CEO. Get in touch with AWS here to learn how we can help your organization accelerate healthcare innovation.Please take a moment and let us know what you think of the podcast, access our feedback survey here.

In this special crossover episode, we're joined by Tjaša Zajc, Host of the Faces of Digital Health Podcast. Faces of Digital Health is a show that explores the diversity of healthcare systems and healthcare innovation worldwide. Together with Alex Merwin, Head of Growth, Healthcare & Life Science Startups at AWS, and executive producer of the AWS Health Innovation Podcast, we'll speak about the mission of both podcasts, our professional journeys, and the challenges health systems and entrepreneurs face as they embrace digital transformation. About the Faces of Digital Health Podcast: Tjaša Zajc shares more information about her podcast, which features a diverse range of healthcare systems worldwide. We highlight a few examples of challenges and opportunities for health systems who are embracing digital transformation. About the AWS Health Innovation Podcast: Alex Merwin shares details about how AWS works with healthcare & life sciences startups, and the role the podcast has in highlighting health innovation from high-potential startups challenging the status quo worldwide. Advice for Founders: Closing thoughts and advice for early-stage founders looking to make a difference in Healthcare. Health Innovation Trends: Startup funding, technology and other health innovation trends, including a discussion on health innovation in Africa. Host Background: Alex and Tjaša share their professional journies and what inspired them to focus on accelerating health innovation. Staying in Touch: Keeping up to speed on both the shows and how to get in touch. Subscribe to the Faces of Digital Health Podcast here or wherever you listen to podcasts. Get in touch with AWS here to learn how we can help your organization accelerate healthcare innovation.Please take a moment and let us know what you think of the podcast, access our feedback survey here.

Dr. Serafim Batzoglou, Chief Data Officer at Seer joins Dr. Amrita Sarkar, Principal Healthcare and Life Sciences Startups Business Development Manager at AWS Startups to talk about Seer's pioneering work to decode the secrets of the proteome to improve human health. if the genome were a basic map of a city, then the proteome would be Street View, capturing every detail down to the graffiti and the potholes. Seer is pioneering new ways to decode the secrets of the proteome, leveraging engineered nanoparticles to provide unbiased, deep, and large-scale access to this incredibly detailed landscape. Here's what we cover: The Proteome Puzzle [02:16]: Dr. Amrita Sarkar and Serafim Batzoglou dive into the complexities of the proteome and how it offers a more dynamic view of human biology than the genome. They discuss why proteomics has lagged behind genomics in terms of tools to characterize structure & function. Serafim's Journey [06:47]: Learn about Serafim Batzoglou's academic background and his transition from academia to industry, with his experience in computational biology and genomics setting the stage for his current role at Seer. Seer's Innovation [13:55]: Seer's nanoparticle technology is revolutionizing proteomics by enabling deep, scalable analysis of accessible proteomes like plasma. AI Meets Biology [17:04]: We explore the convergence of cloud computing, AI, and biology, focusing on how Large Language Models have the potential to revolutionize our understanding of complex biological systems. Here is the article Amrita mentions which Serafiim authored on this topic. Scaling Challenges [22:44]: Scaling Seer's technology presents scientific and business challenges. We highlight the cultural divide between genomics and proteomics and the need for tools which span these worlds more effectively. Team Dynamics [26:05]: Building a successful TechBio startup requires a diverse multi-disciplinary team. Serafim shares best practices on creating high-performing TechBio teams. Advice for Founders [29:23]: Serafim shares insights for aspiring life sciences entrepreneurs, emphasizing the long-term nature of biotech and the importance of building a business model that consistently funds data acquisition. Get in touch with AWS here to learn how we can help your organization accelerate healthcare innovation. Please take a moment and let us know what you think of the podcast, access our feedback survey here.

In this episode, Alex Merwin, Head of Growth for Healthcare & Life Sciences Startups at AWS, speaks with Guillaume de Zwirek, Co-Founder & CEO of Artera, a unified patient communication platform delivering happier staff, healthier patients, and more profitable organizations.We discuss how technology can make navigating the healthcare system feel less like a maze, board meetings with dolphins, and how Amazon's peculiar ways of working can help startups scale. Background [02:43]: Guillaume de Zwirek discusses his unique background as an athlete and jazz musician, and how these experiences influenced his decision to start Artera. Patient Engagement Platform [07:51]: An overview of Artera's solution, which aims to revolutionize healthcare customer experience by providing a single phone number for patient engagement. Importance of Flexibility [10:51]: We explore the versatility of Artera's platform, highlighting its adaptability for various clinical and non-clinical use cases, and its role in spreading best practices. Customer-Centricity [13:54]: Guillaume shares Artera's customer-centric culture, inspired by Amazon, and discusses strategies like spending 30% of his time with customers to keep their needs front and center. Growth Strategies [21:17]: Artera's growth strategies, including a writing-focused culture and weekly strategic reviews, partly inspired by Amazon's peculiar ways of working. Marketplace & API [24:47]: Introduction to Artera's marketplace, which allows third-party digital health innovators to integrate seamlessly into Artera's patient communication platform. Future Ambitions [28:21]: Guillaume outlines his future ambitions for Artera, focusing on visibility and orchestration features, and cautiously explores the potential role of Generative AI in healthcare. Advice for Founders [36:01]: The episode wraps up with Guillaume offering valuable advice for other startup founders, emphasizing the importance of learning from mistakes and staying close to customers. Get in touch with AWS here to learn how we can help your organization accelerate healthcare innovation. Please take a moment and let us know what you think of the podcast, access our feedback survey here.

Hear from top healthcare startups on the AI revolution in healthcare. Topics include responsible AI development, future of AI in drug development, achieving product-market fit for radiology solutions, evidence generation for echocardiography, unique regulatory strategy for AI in dentistry, maintaining well-architected data environments, sourcing diverse datasets to reduce health inequities, and the importance of data reliability in healthcare AI.